SERUM-MONOAMINE-OXIDASE LEVELS DURING LEVODOPA THERAPY
- 24 April 1971
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 297 (7704) , 859
- https://doi.org/10.1016/s0140-6736(71)91528-5
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- A Clinical Evaluation of Serum Monoamine Oxidase, with Special Reference to Hepatic FibrosisDigestion, 1971
- Determination of Monoamine Oxidase Activity in Human Blood Serum with14C-Butylamine as SubstrateScandinavian Journal of Clinical and Laboratory Investigation, 1970
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Physiological and Pathological Influences on Serum Monoamine Oxidase Level: Effect of Age, Sex, Contraceptive Steroids and Diabetes MellitusScandinavian Journal of Clinical and Laboratory Investigation, 1969
- SERUM MONOAMINE OXIDASE (MAO) IN DIABETES MELLITUS AND SOME OTHER INTERNAL DISEASESActa Medica Scandinavica, 1968
- Human Plasma Monoamine OxidasePublished by Elsevier ,1965